Status:
COMPLETED
Billroth II or Roux-en-Y Reconstruction for GJ After PD: Randomized Controlled Trial (PAUDA TRIAL)
Lead Sponsor:
Hospital Universitari de Bellvitge
Conditions:
Malignant Neoplasm of Head of Pancreas
Eligibility:
All Genders
Phase:
NA
Brief Summary
The aim of the study is to compare the effect of Roux-en Y reconstruction (study group, DPCDA) versus classical Child reconstruction (DPCUN) in the incidence of VGL in patients for DPC. The hypotesis ...
Detailed Description
The pancreaticoduodenectomy (DPC) is the procedure of choice of the tumors of the head of the pancreas, periampullary tumors and intractable inflammatory pathology. The high postoperative morbidity (...
Eligibility Criteria
Inclusion
- Patients with pancreatic head cancer considered resectable after the extension study
- Patients suffering from periampullary tumors considered resectable after the extension study
- Patients suffering from pancreatic inflammatory disease with medically intractable pain
- Patients who have read the information sheet of the study and signed the informed consent form
Exclusion
- Patients with history of previous gastrectomy
- Patients with associated resections of other organs, except for the superior portal vein or mesenteric vein
- Patients with enlargement to total pancreatectomy
- Patients who has recieved neoadjuvant treatment
- Patients with plastic peritonitis
- Patients with liver cirrhosis.
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT02246205
Start Date
February 1 2013
End Date
April 1 2015
Last Update
October 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitari de Bellvitge
Hospitalet Llobregat, Barcelona, Spain, 08907